ArticleTransfusion2026
Identification of IV fluid contamination in complete blood counts and subsequent unnecessary red blood cell transfusions using artificial intelligence.
Article in Transfusion, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSpecimens contaminated with intravenous (IV) fluids can lead to considerable measurement errors in complete blood counts (CBCs), posing challenges for laboratory operations and clinical decision-making. There is no gold-standard method for retrospectively identifying these events, making it difficult to target quality improvement initiatives or optimize laboratory detection protocols. STUDY DESIGN AND
methodsThis study aimed to develop and validate machine learning (ML) models to retrospectively identify IV fluid contamination in CBC results at scale across two institutions. The models were trained on simulated contamination in CBCs using prior, current, and post hemoglobin concentrations, platelet counts, and white blood cell counts, then validated against expert-reviewed datasets. Real-world applicability was assessed using 1 year's worth of CBC results from each institution.
resultsThe models effectively discriminated contaminated from non-contaminated results on real-world datasets, with areas under the receiver operating characteristic curve of 0.972 and 0.957, and areas under the precision-recall curve of 0.723 and 0.619. In 1 year of CBC data, ~2% of inpatient CBC trios were predicted as contaminated across both institutions. 6%-9% of inpatient transfusions for which a CBC trio was available were deemed potentially unnecessary using a rule set validated by expert chart review. DISCUSSION: The findings support the feasibility of using ML to identify IV fluid contamination in CBC results efficiently and effectively. Further work, including prospective real-world evaluations, targeted quality improvement initiatives, and development of real-time detection models, is necessary before realizing the potential benefits to patient safety, laboratory operations, and patient blood management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.